239 Ribosomal protein L25-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organic acids and derivatives | 15 | 7.8 | 1.93× | q = 0.02 | |
| Homogeneous metal compounds | 36 | 24.7 | 1.46× | q = 4.1e-3 | |
| Nucleosides, nucleotides, and analogues | 15 | 13.9 | 1.08× | q = 0.82 | |
| Homogeneous non-metal compounds | 6 | 10.8 | 0.55× | q = 0.17 | |
| Lipids and lipid-like molecules | 0 | 5.6 | 0 | q = 0.01 | |
| Organic oxygen compounds | 0 | 10.0 | 0 | q < 0.0001 | |
| Organoheterocyclic compounds | 0 | 7.7 | 0 | q = 1.4e-3 | |
| Mixed metal/non-metal compounds | 4 | 1.1 | 3.79× | not tested | |
| Organic nitrogen compounds | 1 | 1.6 | 0.62× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB16833 | ADP | Adenosine disphosphate | 118 |
| DB00130 | GLN | L-Glutamine | 96 |
| DB00131 | AMP | Adenosine phosphate | 41 |
| DB02663 | PPQ | 2-Amino-4-(Hydroxymethyl-Phosphinyl)Butanoic Acid | 15 |
| DB00142 | GLU | Glutamic acid | 8 |
| DB00171 | ATP | ATP | 7 |
| DB08818 | — | — | 5 |
| DB00120 | PHE | Phenylalanine | 3 |
| DB14103 | MSL | Methionine sulfoximine | 3 |
| DB02510 | — | 5'-O-(L-Prolylsulfamoyl)adenosine | 2 |
| DB02684 | — | 5'-O-(L-Cysteinylsulfamoyl)adenosine | 2 |
| DB03566 | SPD | Spermidine | 2 |
| DB03909 | ACP | Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 479 |
| P3S | L-METHIONINE-S-SULFOXIMINE PHOSPHATE | 94 |
| GLN | GLUTAMINE | 86 |
| OHX | osmium (III) hexammine | 84 |
| CL | CHLORIDE ION | 65 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 56 |
| AKG | 2-OXOGLUTARIC ACID | 48 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 28 |
| PEB | PHYCOERYTHROBILIN | 28 |
| NImetal | NICKEL (II) ION | 24 |
| P3P | (2S)-2-AMINO-4-[METHYL(PHOSPHONOOXY)PHOSPHORYL]BUTANOIC ACID | 20 |
| NAmetal | SODIUM ION | 12 |
| TLmetal | THALLIUM (I) ION | 12 |
| ZNmetal | ZINC ION | 12 |
| MSL | (2S)-2-AMINO-4-(METHYLSULFONIMIDOYL)BUTANOIC ACID | 10 |
| ANP | PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER | 7 |
| CAmetal | CALCIUM ION | 7 |
| AMP | ADENOSINE MONOPHOSPHATE | 5 |
| Kmetal | POTASSIUM ION | 5 |
| CDmetal | CADMIUM ION | 4 |